Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company?) is pleased to announce a jointly signed letter of intent for the acquisition of DNAPrint Genomics, Inc...
NEW YORK, Sept. 7 /PRNewswire-FirstCall/ -- Richard Gabriel, Chief Executive Officer of DNAPrint Genomics, Inc. (OTC:DNAG) (BULLETIN BOARD: DNAG) (http://www.dnaprint.com/) will be featured in...
DNAPrint genomics Launches New Corporate Marketing and Product Branding Campaign Features Two Redesigned and Upgraded Web Sites SARASOTA, Fla., July 25 /PRNewswire-FirstCall/ -- DNAPrint...
DNAPrint genomics' Forensics Technology Featured in Presentation to Florida Sex Crimes Investigators Association SARASOTA, Fla., July 18 /PRNewswire-FirstCall/ -- DNAPrint genomics...
DNAPrint genomics Acquires 18% Stake in German Company Creates New Product Pipeline for Pharmaceutical Products SARASOTA, Fla., July 13 /PRNewswire-FirstCall/ -- DNAPrint genomics...
DNAPrint genomics Upgrades Genotyping Platform SARASOTA, Fla., July 12 /PRNewswire-FirstCall/ -- DNAPrint genomics, Inc. (OTC:DNAG) (BULLETIN BOARD: DNAG) today announced an upgrade in the...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 5017787 | 1.0E-6 | CS |
12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 1737804 | 1.0E-6 | CS |
26 | 0 | 0 | 1.0E-6 | 0.000134 | 1.0E-6 | 803500 | 1.0E-6 | CS |
52 | 0 | 0 | 1.0E-6 | 0.000134 | 1.0E-6 | 485985 | 1.0E-6 | CS |
156 | 0 | 0 | 1.0E-6 | 0.000134 | 1.0E-6 | 162901 | 1.06E-6 | CS |
260 | -9.9E-5 | -99 | 0.0001 | 0.001 | 1.0E-6 | 780443 | 0.0003396 | CS |
銘柄コード | 株価 | 出来高 |
---|---|---|
ADGOAdvantego Corporation (CE) | US$ 0.000001 (0.00%) | 99.65M |
GRLFGreen Leaf Innovations Inc (PK) | US$ 0.0001 (0.00%) | 48.16M |
PHILPHI Group Inc (PK) | US$ 0.0004 (-20.00%) | 44.11M |
HCMCHealthier Choices Management Corporation (PK) | US$ 0.000001 (0.00%) | 39.38M |
LFAPLGBTQ Loyalty Holdings Inc (CE) | US$ 0.000001 (0.00%) | 26.61M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約